DIN 02483637 — CRYSVITA 20 MG
CRYSVITA is a solution of Burosumab marketed by KYOWA KIRIN, INC.. The full Burosumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02483637
- Brand name
- CRYSVITA
- Active ingredient
- Burosumab
- Strength
- 20 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- KYOWA KIRIN, INC.
- Health Canada status
- MARKETED
- Drug class
- Fibroblast growth factor 23 (FGF23) inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Burosumab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02483629 | CRYSVITA | 10 MG | SOLUTION | KYOWA KIRIN, INC. | MARKETED |
| 02483645 | CRYSVITA | 30 MG | SOLUTION | KYOWA KIRIN, INC. | MARKETED |